← Leaderboards
Hongbo R Luo
Children'S Hospital Boston
$26,444,831
Attributed
$26,444,831
Total exposure
18
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,805,025 · 20
By mechanism
R01$20,075,025 · 10
P01$18,221,503 · 8
R21$423,997 · 1
R03$84,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsNeutrophilInfectionCellsMediatingHost DefensePathogenIn VivoSignal TransductionInsightInflammationNew Therapeutic TargetRegulationBaseInvadedCessation Of LifePreventMembraneBacteriaNeutropeniaPhagocytosisMolecularLifeChemotaxis
Grant awards (71)
Novel Strategies to Improve Blood Transfusion Practice$2,578,863
P01 · FY2025 · HL · contact PI
Characterization of lung interstitial neutrophils$710,302
R01 · FY2025 · HL · contact PI
Extending neutrophil survival in neutropenia-related pneumonia$676,748
R01 · FY2025 · HL · contact PI
Novel Strategies to Improve Blood Transfusion Practice$2,540,895
P01 · FY2024 · HL · contact PI
Novel Strategies to Improve Blood Transfusion Practice$2,590,165
P01 · FY2023 · HL · contact PI
Improving granulocyte transfusion in neutropenia-related infections$664,715
P01 · FY2023 · HL · contact PI
Regulation of neutrophil death by GSDMD in Candida albicans infection$308,664
R01 · FY2023 · AI · contact PI
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation$277,958
R01 · FY2023 · AI · contact PI
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation$165,304
R01 · FY2023 · AI · contact PI
Regulation of neutrophil death by GSDMD in Candida albicans infection$135,349
R01 · FY2023 · AI · contact PI
Administrative Core$132,182
P01 · FY2023 · HL · contact PI
Novel Strategies to Improve Blood Transfusion Practice$2,655,358
P01 · FY2022 · HL · contact PI
Improving granulocyte transfusion in neutropenia-related infections$681,450
P01 · FY2022 · HL · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$442,500
R01 · FY2022 · HL · contact PI
Cell-based high-throughput chemical genetic screening for GSDMD inhibitors$442,500
R01 · FY2022 · AI · contact PI
Regulation of neutrophil death by GSDMD in Candida albicans infection$442,500
R01 · FY2022 · AI · contact PI
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation$442,500
R01 · FY2022 · AI · contact PI
Administrative Core$132,182
P01 · FY2022 · HL · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$442,500
R01 · FY2021 · HL · contact PI
Regulation of neutrophil death by GSDMD in Candida albicans infection$442,500
R01 · FY2021 · AI · contact PI
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation$442,500
R01 · FY2021 · AI · contact PI
Cell-based high-throughput chemical genetic screening for GSDMD inhibitors$442,500
R01 · FY2021 · AI · contact PI
Molecular Mechanisms of Blood Cell Transfusion$1,994,913
P01 · FY2020 · HL · contact PI
Cell signaling in granulocyte transfusion$445,696
P01 · FY2020 · HL · contact PI
Regulation of neutrophil death by GSDMD in Candida albicans infection$442,500
R01 · FY2020 · AI · contact PI
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation$442,500
R01 · FY2020 · AI · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$442,500
R01 · FY2020 · HL · contact PI
Cell-based high-throughput chemical genetic screening for GSDMD inhibitors$442,500
R01 · FY2020 · AI · contact PI
Cell signaling in granulocyte transfusion$445,696
P01 · FY2019 · HL · contact PI
Regulation of neutrophil death by GSDMD in Candida albicans infection$442,500
R01 · FY2019 · AI · contact PI
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation$442,500
R01 · FY2019 · AI · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$442,500
R01 · FY2019 · HL · contact PI
Cell-based high-throughput chemical genetic screening for GSDMD inhibitors$442,500
R01 · FY2019 · AI · contact PI
Regulation of neutrophil function by ROS-induced actin glutathionylation$442,500
R01 · FY2018 · AI · contact PI
Cell signaling in granulocyte transfusion$436,781
P01 · FY2018 · HL · contact PI
Cell signaling in granulocyte transfusion$445,696
P01 · FY2017 · HL · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$442,500
R01 · FY2017 · HL · contact PI
Regulation of neutrophil function by ROS-induced actin glutathionylation$442,500
R01 · FY2017 · AI · contact PI
Cell signaling in granulocyte transfusion$451,048
P01 · FY2016 · HL · contact PI
Regulation of neutrophil function by ROS-induced actin glutathionylation$442,500
R01 · FY2016 · AI · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$442,500
R01 · FY2016 · HL · contact PI
Regulation of neutrophil function by ROS-induced actin glutathionylation$441,042
R01 · FY2015 · AI · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$434,631
R01 · FY2015 · HL · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$438,750
R01 · FY2014 · HL · contact PI
Regulation of neutrophil function by ROS-induced actin glutathionylation$438,542
R01 · FY2014 · AI · contact PI
Cell signaling in granulocyte transfusion$399,022
P01 · FY2014 · HL · contact PI
Cell signaling in granulocyte transfusion$390,171
P01 · FY2013 · HL · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$430,650
R01 · FY2012 · HL · contact PI
Cell signaling in granulocyte transfusion$413,232
P01 · FY2012 · HL · contact PI
HTS for enhancers of neutrophil function that specifically augment PIP3 signal$383,710
R01 · FY2012 · AI · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$434,167
R01 · FY2011 · HL · contact PI
Cell signaling in granulocyte transfusion$412,482
P01 · FY2011 · HL · contact PI
HTS for enhancers of neutrophil function that specifically augment PIP3 signal$380,770
R01 · FY2011 · AI · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$429,583
R01 · FY2010 · HL · contact PI
Molecular basis of neutrophil spontaneous death$422,500
R01 · FY2010 · HL · contact PI
Cell signaling in granulocyte transfusion$410,956
P01 · FY2010 · HL · contact PI
HTS for enhancers of neutrophil function that specifically augment PIP3 signal$381,645
R01 · FY2010 · AI · contact PI
Signal transduction in neutrophil chemotaxis$300,548
R01 · FY2010 · GM · contact PI
Enhancing neutrophil function in neutropenia-related pneumonia$426,667
R01 · FY2009 · HL · contact PI
Molecular basis of neutrophil spontaneous death$422,500
R01 · FY2009 · HL · contact PI
HTS for enhancers of neutrophil function that specifically augment PIP3 signal$381,750
R01 · FY2009 · AI · contact PI
Signal transduction in neutrophil chemotaxis$303,583
R01 · FY2009 · GM · contact PI
Molecular basis of neutrophil spontaneous death$292,346
R01 · FY2009 · HL · contact PI
Molecular basis of neutrophil spontaneous death$422,500
R01 · FY2008 · HL · contact PI
Signal transduction in neutrophil chemotaxis$303,583
R01 · FY2008 · GM · contact PI
Molecular basis of neutrophil spontaneous death$422,500
R01 · FY2007 · HL · contact PI
Signal transduction in neutrophil chemotaxis$303,583
R01 · FY2007 · GM · contact PI
Signal transduction in neutrophil chemotaxis$312,650
R01 · FY2006 · GM · contact PI
InsP7 in glutamate excitotoxicity$228,976
R21 · FY2006 · NS · contact PI
High throughput screening for inhibitors of Akt plasma m$84,500
R03 · FY2006 · NS · contact PI
InsP7 in glutamate excitotoxicity$195,021
R21 · FY2005 · NS